Endothelin as a Proinflammatory Mediator

János G. Filep,Douglas W. P. Hay
DOI: https://doi.org/10.1007/978-3-0348-8821-9_10
1999-01-01
Abstract:Pulmonary host-defense is often characterized by either acute or chronic inflammatory response to a given challenge. Acute inflammation is the host’s stereotyped response to a variety of insults such as infection, trauma, allograft rejection and ischemia-reperfusion. This defense mechanism may be summarized by the following, often overlapping, “steps”: (a) injury to the host and local generation of mediators; (b) recruitment of inflammatory cells (e.g., neutrophils, eosinophils) at the site of injury, an event always associated with increased microvascular permeability; (c) destruction and/or phagocytosis of invading organisms and tissue debris; (d) removal of inflammatory cells and debris; (e) tissue remodeling and repair, leading to resolution and restoration of normal lung function. Modern perceptions have emphasized the detrimental effects of inflammation and its association with disease. Indeed, inflammation is the basis of a variety of pulmonary diseases such as asthma and acute respiratory distress syndrome (ARDS). In these pathologies, persisting stimuli or injury results in tissue destruction and ongoing (chronic) inflammation that fails to resolve and that may culminate in end-stage fibrosis. Although the specific molecular mechanisms that result in acute or chronic inflammation have not been fully elucidated, it is now clear that humoral mediators and interactions between immune and non-immune cells are integral to our understanding of the pathogenesis of pulmonary inflammation.
What problem does this paper attempt to address?